AMWL - NYSE
American Well Corporation
$8.46
+0.65%American Well Corporation operates as a telehealth software company that enables digital delivery of care for healthcare. The company products offer urgent care; scheduled visits; acute behavioral health; telestroke; pediatrics; retail health, school health, and home settings. Its application offers urgent care; pediatrics; therapy; menopause nutrition; end-stage renal disease and dialysis; dermatology care; behavioral health therapy; and musculoskeletal care. The company also provides telemedicine equipment, including telemedicine carts, peripherals, tyto care, TV kits, tablets, and kiosks. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.
At a Glance
Live SnapshotAmerican Well Corporation Profit Bridge
Profitability Analysis
Gross Margin
Exceptional pricing power and cost management. The company retains over half of revenue after direct costs.
Operating Margin
Operating losses indicate the core business is unprofitable. Requires restructuring or revenue growth.
Net Profit Margin
Net losses indicate the company is burning cash. Sustainability depends on path to profitability.
Profitability Insight
Margin squeeze alert: Healthy gross margins but weak operating margins suggest excessive operating expenses. Cost optimization could unlock significant value.
American Well Corporation Income Statement
AMWL • NYSE
| American Well Corporation Income Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 |
|---|---|---|---|---|---|---|---|---|
REVENUE | ||||||||
249.3M | 254.4M | 259M | 277.2M | 252.8M | 245.3M | 148.9M | 114M | |
GROSS PROFIT | ||||||||
(116.5M) | (155.4M) | (164.3M) | (160.4M) | (148.5M) | (166.9M) | (80M) | (58.6M) | |
132.9M | 99M | 94.8M | 116.8M | 104.3M | 78.3M | 68.9M | 55.3M | |
OPERATING INCOME | ||||||||
(238.1M) | (316.5M) | (786.9M) | (392.6M) | (283.5M) | (299.3M) | (163.6M) | (110.4M) | |
(131.3M) | (197.4M) | (213.1M) | (228M) | (160.8M) | (214.9M) | (101.9M) | (68.8M) | |
(72.9M) | (86.1M) | (105.8M) | (138.5M) | (106.6M) | (84.4M) | (53.9M) | (36.3M) | |
-105.3M | -217.5M | -692.1M | -275.9M | -179.1M | -221M | -94.7M | -55.1M | |
PRE-TAX INCOME | ||||||||
3.8M | 10.8M | 19.4M | 6.1M | 120K | 1.6M | 5.5M | 2.8M | |
(34M) | (33M) | (468M) | (26.2M) | (16.1M) | (0.0) | (7.8M) | (5.3M) | |
10.7M | 7.6M | 16.8M | 3.8M | -3M | -7M | 5.5M | 2.8M | |
-94.5M | -209.9M | -675.3M | -272M | -182.2M | -228M | -89.2M | -52.3M | |
NET INCOME | ||||||||
(434K) | (2.8M) | (3.9M) | (64K) | -5.4M | (639K) | -803K | (0.0) | |
-95.7M | -208.1M | -675.2M | -270.4M | -176.3M | -224.4M | -88.4M | -52.7M |
SEC Filings
AMWL - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2026 N/A | May 12, 2026 | May 06, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | May 05, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 05, 2026 | May 05, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | April 23, 2026 | April 23, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 02, 2026 | April 01, 2026 | 2026 | |
10-K 10-K 2025 FY FY | February 12, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | February 12, 2026 | February 12, 2026 | 2026 | |
8-K 8-K 2026 N/A | January 08, 2026 | January 05, 2026 | 2026 | |
8-K 8-K 2025 N/A | January 02, 2026 | December 24, 2025 | 2025 | |
10-Q 10-Q 2025 Q3 Q3 | November 04, 2025 | September 30, 2025 | 2025 |
Related Guides
Continue your AMWL research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.